Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ultralife's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 65.85.
Ultralife's Days Inventory for the
three
months ended in Jun. 2026 was 155.35.
Ultralife's Days Payable for the
three
months ended in Jun. 2026 was 62.47.
Therefore, Ultralife's Cash Conversion Cycle (CCC) for the
three
months ended in Jun. 2026 was 158.73.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Ultralife Cash Conversion Cycle Related Terms
Ultralife Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Ultralife's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ULBI vs NMAD, TGEN, APWC: Cash Conversion Cycle Comparison
For the Electrical Equipment & Parts subindustry, Ultralife's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultralife Cash Conversion Cycle vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Ultralife's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Ultralife's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Ultralife's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ultralife (ULBI) has a Cash Conversion Cycle of 158.73 as of Jun. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Ultralife and its competitors.
Is Ultralife's Cash Conversion Cycle too high?
Ultralife's current Cash Conversion Cycle is 158.73. The Industrial Products industry median Cash Conversion Cycle is 121.21. Ultralife's value of 158.73 is 31% above this industry median. Overall, Ultralife has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ultralife's Cash Conversion Cycle compare to NMAD and TGEN?
Ultralife's Cash Conversion Cycle of 158.73 can be compared against companies in the Industrial Products industry. The industry median Cash Conversion Cycle is 121.21. Ultralife's value of 158.73 is 31% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Industrial Products company?
The median Cash Conversion Cycle among Industrial Products companies is 121.21, based on 3,044 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultralife's current Cash Conversion Cycle of 158.73 is 31% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Ultralife and its competitors. For the Industrial Products industry, the median Cash Conversion Cycle is 121.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultralife's current Cash Conversion Cycle is 158.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultralife stock overvalued right now?
Based on GuruFocus' analysis, Ultralife (ULBI) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.95, compared to a current price of $6.56 — trading 26.7% below its estimated fair value. The current Cash Conversion Cycle is 158.73 and 31% above the Industrial Products industry median of 121.21. Ultralife's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Ultralife (ULBI), the current Cash Conversion Cycle is 158.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ultralife (ULBI) Overvalued in 2026?
Based on GuruFocus' analysis, Ultralife stock appears to be undervalued.
The current stock price of $6.56 is trading 26.7% below its estimated GF Value™ of $8.95.
GuruFocus considers Ultralife to be Modestly Undervalued.
Key valuation signals for ULBI:
Cash Conversion Cycle: 158.73
GF Value™: $8.95 vs. price of $6.56 (26.7% below fair value)
Industry Position: 31% above the Industrial Products median
No single metric tells the full story. See the ULBI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
72GF Score
Get the complete analysis for ULBI
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ULBI has been successfully added to your 
